|

RLY-8161 Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Relay Therapeutics, Inc.1

Indications

  • Advanced NRAS-Mutant Solid Tumors1
  • Advanced NRAS-Mutant Melanoma1
  • NRAS G12V1
  • NRAS G13D1
  • NRAS G13R1

Los Angeles, California1 trial

A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid Tumors

University of California, Los Angeles

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.